MesalazineHydrops fetalis, fetal haemolytic anaemia and various complication following in utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1686卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41299-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：236 / 236

相关论文

共 50 条

[1] DapsoneMethaemoglobinaemia and haemolytic anaemia following accidental exposure: case report
Reactions Weekly, 2022, 1929 (1) : 225 - 225
[2] SulfasalazineHaemolytic anaemia in a fetus following in utero exposure: case report
Reactions Weekly, 2006, 1097-1098 (1) : 22 - 22
[3] Cytarabine/daunorubicinFetal anaemia following in utero exposure: case report
Reactions Weekly, 2010, 1294 (1) : 16 - 16
[4] DeferoxamineIron deficiency anaemia (first report) following in utero exposure: case report
Reactions Weekly, 2007, 1154 (1) : 11 - 11
[5] Cytarabine/daunorubicin/tioguanineFetal anaemia following in utero exposure: case report
Reactions Weekly, 2008, 1218 (1) : 14 - 14
[6] MethotrexateMultiple fetal abnormalities following in utero exposure: case report
Reactions Weekly, 2002, 904 (1) : 10 - 10
[7] Cyclophosphamide/doxorubicinPrematurity, neutropenia and anaemia in a neonate following in utero exposure: case report
Reactions Weekly, 2005, 1047 (1) : 8 - 8
[8] BenazeprilFirst report of fatal fetal disorders following in utero exposure: case report
Reactions Weekly, 2002, 915 (1) : 5 - 5
[9] TrastuzumabAnhydramnios and fetal growth retardation following in utero exposure: case report
Reactions Weekly, 2007, 1164 (1) : 23 - 23
[10] Oxcarbazepine/topiramateMultiple fetal anomalies following in utero exposure: case report
Reactions Weekly, 2012, 1407 (1) : 32 - 32

← 1 2 3 4 5 →